Post-COVID-19 Seasonality of Influenza, Respiratory Syncytial Virus, and SARS-CoV-2 Among Hospitalized Children in Western Iran: A Molecular Surveillance Study (2023–2024)
Open Access
- 9 December 2025
- journal article
- research article
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 15 (1) , 146
Abstract
Background: This study aimed to characterize the incidence, seasonality, and co-infection patterns of respiratory syncytial virus (RSV), influenza A and B, and SARS-CoV-2 among hospitalized children aged 0–5 years in Hamedan Province, a semi-arid region in western Iran, from April 2023 to March 2024. Key research questions included assessing post-pandemic shifts in viral seasonality, evaluating the extent of RSV circulation, and determining the frequency of co-infections in a resource-limited pediatric setting where regional data remain scarce. Methods: A total of 586 nasopharyngeal/oropharyngeal samples were collected from children aged 0–5 years hospitalized with acute respiratory symptoms (≥ 2 of: fever ≥ 38 °C, cough, dyspnea, oxygen saturation < 95%). Multiplex real-time PCR (sensitivity 95%, specificity 98%) was used to detect RSV, SARS-CoV-2, and influenza A (H1N1, H3N2) and B. Statistical analysis included chi-square and Fisher’s exact tests, and generalized linear models (binomial distribution, logit link). Results: Among 586 inpatients (mean age: 2.8 years; 62.5% male), 27.0% tested positive for influenza (60% influenza A [35% H1N1, 25% H3N2], 40% influenza B), 6.0% for RSV, and 6.3% for SARS-CoV-2. Influenza peaked in autumn (41.3%, p < 0.001), RSV in winter (18.2%, p < 0.001), and SARS-CoV-2 in spring (15.3%, p = 0.005). Co-infections were rare (0.9%). Conclusions: Findings reveal altered post-pandemic seasonality, reduced RSV activity, and low co-infection rates, suggesting potential ecological and immunological shifts. These trends highlight the need for sustained virus-specific surveillance and recalibrated vaccination strategies—particularly influenza vaccination in autumn and RSV prophylaxis in winter—in resource-limited pediatric settings.Keywords
All Related Versions
Funding Information
- Hamadan University of Medical Sciences
This publication has 34 references indexed in Scilit:
- Cycles of Susceptibility: Immunity Debt Explains Altered Infectious Disease Dynamics Post-PandemicClinical Infectious Diseases, 2024
- Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patientsInternational Journal of Infectious Diseases, 2024
- Differential responses of SARS-CoV-2 variants to environmental drivers during their selective sweepsScientific Reports, 2024
- Epidemiology and clinical features of respiratory syncytial virus (RSV) infection in hospitalized children during the COVID‐19 pandemic in Gorgan, IranHealth Science Reports, 2024
- Clinical impact of human parainfluenza virus infections before and during the COVID-19 pandemic in Southern ChinaMicrobes and Infection, 2023
- Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regressionThe Lancet Infectious Diseases, 2023
- A delayed resurgence of respiratory syncytial virus (RSV) during the COVID‐19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022Journal of Medical Virology, 2022
- Off-season RSV epidemics in Australia after easing of COVID-19 restrictionsNature Communications, 2022
- Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysisThe Lancet, 2022
- Determination of genetic characterization and circulation pattern of Respiratory Syncytial Virus (RSV) in children with a respiratory infection, Tehran, Iran, during 2018-2019Virus Research, 2021